Studies using models of IBD have shown that CD4+T cells play a major role in initiating and shaping the syndrome and that their capacity to extend gut inflammation is largely dependent on the production of distinct cytokine profiles [37]. The gene discussed is CD4; the disease is irritable bowel syndrome.